Janux Therapeutics Inc's total assets for Q4 2023 were $380.41M, a decrease of -1.67% from the previous quarter. JANX total liabilities were $36.06M for the fiscal quarter, a -4.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.